- Home
- IAS vs PRAX Comparison
IAS vs PRAX Comparison
Compare IAS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAS
- PRAX
- Stock Information
- Founded
- IAS 2009
- PRAX 2015
- Country
- IAS United States
- PRAX United States
- Employees
- IAS N/A
- PRAX N/A
- Industry
- IAS Computer Software: Programming Data Processing
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- IAS Technology
- PRAX Health Care
- Exchange
- IAS Nasdaq
- PRAX Nasdaq
- Market Cap
- IAS 1.8B
- PRAX 1.5B
- IPO Year
- IAS 2021
- PRAX 2020
- Fundamental
- Price
- IAS $10.15
- PRAX $78.26
- Analyst Decision
- IAS Buy
- PRAX Strong Buy
- Analyst Count
- IAS 11
- PRAX 9
- Target Price
- IAS $14.80
- PRAX $149.11
- AVG Volume (30 Days)
- IAS 768.9K
- PRAX 309.5K
- Earning Date
- IAS 02-25-2025
- PRAX 03-04-2025
- Dividend Yield
- IAS N/A
- PRAX N/A
- EPS Growth
- IAS 258.32
- PRAX N/A
- EPS
- IAS 0.20
- PRAX N/A
- Revenue
- IAS $511,358,000.00
- PRAX $1,605,000.00
- Revenue This Year
- IAS $11.97
- PRAX N/A
- Revenue Next Year
- IAS $11.96
- PRAX N/A
- P/E Ratio
- IAS $51.86
- PRAX N/A
- Revenue Growth
- IAS 11.77
- PRAX N/A
- 52 Week Low
- IAS $7.98
- PRAX $33.01
- 52 Week High
- IAS $17.53
- PRAX $86.93
- Technical
- Relative Strength Index (RSI)
- IAS 46.51
- PRAX 57.53
- Support Level
- IAS $9.86
- PRAX $60.07
- Resistance Level
- IAS $10.15
- PRAX $71.21
- Average True Range (ATR)
- IAS 0.32
- PRAX 4.44
- MACD
- IAS 0.02
- PRAX -0.09
- Stochastic Oscillator
- IAS 43.72
- PRAX 85.32
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.